This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Learn the meaning behind the Investor Sentiment Index readings, what drives changes, and how to apply this knowledge to investment decisions.
23,759 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
MannKind reported a double-digit revenue rise, but the stock still slid on Thursday. This article breaks down why the...
On March 2, Ondas surged on news of a $10 million strategic investment and a World View defense partnership. This art...
A notable hedge fund move coincides with Perimeter Solutions' explosive rally. East Coast Asset Management trimmed it...
Ethereum has struggled to clear its late-2025 highs, with on-chain data showing a wave of whale selling even as ETF i...
A hedge fund recently boosted its position in 10x Genomics, highlighting growing confidence in the biotech tools make...
Tilray Brands has evolved from a pure-play cannabis company into a diversified player. This guide breaks down what to...
An oversized insider trade at Check Point Software followed a sharp stock decline. Learn how to interpret this move, ...
The YieldMax TSLA Option Income Strategy ETF drew attention in 2024 for big payouts and a high-yield claim, but its s...
Arm stock skyrocketed this week as AI enthusiasm and licensing momentum collided with bullish analyst coverage. This ...
SpaceX stock surged after its open, then cooled as investors digest fundamentals and macro conditions. This article e...
A high-profile insider move in KE Holdings has prompted questions about BEKE stock and China’s housing market. This a...